Torbay Pharma, a global specialist in the manufacture and supply of terminally sterilised injectables for the secondary care market, has boosted its North American growth strategy by bringing on board industry-leading professionals to strengthen its senior leadership team.
Accelerated by its recent investment from private equity firm, NorthEdge, the contract manufacturer (CMO) and license holder has hired Mohammed Nazir (Naz) as COO and Tara Slivey, CPO, who both have extensive pharma experience in executive roles.
Naz has worked for Pantheon and Pfizer and will be using his operational expertise to support our manufacturing growth plans.
Tara has substantial experience in working in people and cultural development teams and also has experience of working in pharmaceutical manufacturing for businesses owned by private equity.
Emma Rooth, CEO of Torbay Pharma, said: “As we expand in North America we’re staying focused on innovation, efficiency and, most importantly, patient wellbeing. As well as bolstering our leadership team to supercharge our growth, we’re currently working with the FDA to support our bid to gain approval.”
The CMO has already reached a major milestone in its investment plans by completing the first phase of its packaging automation programme, which will significantly speed up the process from manufacturing to release.
